Elsevier,
The Lancet Global Health, Volume 12, January 2024
This Series paper supports SDG 3 by describing several measures of health system quality, which are potential drivers of confidence, including quality of the health system and primary care, government responsiveness to public input, and COVID-19 management; the authors also discuss the policy and research implications.
Elsevier,
The Lancet Global Health, Volume 12, January 2024
This Series paper supports SDG 3 by providing an overview of the current state of health insurance in some African and Asian countries, focusing on how coverage varies across and within countries, and the association between insurance status and use of key preventive health-care services and health system competence.
Elsevier,
Materials Today, Volume 72, 1 January 2024
This article aligns with Sustainable Development Goal 9: Industry, Innovation, and Infrastructure. The research focuses on the green synthesis of nanoparticles using biological entities, such as microorganisms and plants, through nanobiotechnology processes. The use of these environmentally friendly methods has the potential to revolutionize biomedical applications, including cancer detection and treatment, as well as agricultural applications for crop improvement. Furthermore, green nanoparticles show promise in energy production and storage, offering cost-effective and sustainable solutions for future energy demands.
Elsevier,
Engineering Applications of Artificial Intelligence, Volume 127, January 2024
The researchers examined the use of footwear that incorporates force-sensing resistor sensors to classify lower limb disorders affecting the knee, hip, and ankle joints. The outcomes of the study reveal promising findings for future gait analysis and injury diagnosis, and the potential of force-sensing resistors (FSRs) and machine learning techniques for improving the assessment of lower limb injuries, and thereby furthering SDG3.
Elsevier, International Review of Neurobiology, Volume 177, January 2024
Alzheimer's disease (AD) stands as the most prevalent form of neuropsychiatric disorder among the elderly population, impacting a minimum of 50 million individuals worldwide. Current pharmacological treatments rely on the prescribing cholinesterase inhibitors and memantine.
Elsevier, Progress in Brain Research, Volume 289, January 2024
Coffee, a universally consumed beverage, is known to contain thousands of bioactive constituents that have garnered interest due to their potential neuroprotective effects against various neurodegenerative disorders, including Alzheimer's disease (AD).
Elsevier, Studies in Natural Products Chemistry, Volume 81, January 2024
Dementia is a progressive neurological and degenerative syndrome that affects an individuals' memory, thinking, and social abilities severely enough to interfere with their daily lives. It is emerging as a public health priority in terms of the associated disability and mortality.
